BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37872471)

  • 1. Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study.
    Kutzinski M; Krause N; Riemann-Lorenz K; Meyer B; Heesen C
    BMC Neurol; 2023 Oct; 23(1):382. PubMed ID: 37872471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'That would have been the perfect thing after diagnosis': development of a digital lifestyle management application in multiple sclerosis.
    Krause N; Riemann-Lorenz K; Rahn AC; Pöttgen J; Köpke S; Meyer B; Thale F; Temmes H; van de Loo M; Gold SM; Heesen C
    Ther Adv Neurol Disord; 2022; 15():17562864221118729. PubMed ID: 36092248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trial.
    Krause N; Derad C; von Glasenapp B; Riemann-Lorenz K; Temmes H; van de Loo M; Friede T; Asendorf T; Heesen C;
    Mult Scler Relat Disord; 2023 Nov; 79():105043. PubMed ID: 37839367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: a randomised controlled feasibility study.
    Carter AM; Daley AJ; Kesterton SW; Woodroofe NM; Saxton JM; Sharrack B
    Contemp Clin Trials; 2013 Jul; 35(2):40-7. PubMed ID: 23612222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.
    Chruzander C; Gottberg K; Ytterberg C; Backenroth G; Fredrikson S; Widén Holmqvist L; Johansson S
    Disabil Rehabil; 2016 Dec; 38(24):2383-91. PubMed ID: 26750510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-week inpatient energy management education (IEME) for persons with multiple sclerosis-related fatigue: Feasibility of a randomized clinical trial.
    Hersche R; Weise A; Michel G; Kesselring J; Bella SD; Barbero M; Kool J
    Mult Scler Relat Disord; 2019 Oct; 35():26-33. PubMed ID: 31280074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for an online lifestyle modification education course for people living with multiple sclerosis: the multiple sclerosis online course (MSOC).
    Reece JC; Yu M; Bevens W; Simpson-Yap S; Jelinek G; Jelinek P; Davenport R; Nag N; Gray K; Neate S
    BMC Neurol; 2023 Jun; 23(1):249. PubMed ID: 37386385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Don't be late! Postponing cognitive decline and preventing early unemployment in people with multiple sclerosis: a study protocol.
    Aarts J; Saddal SRD; Bosmans JE; de Groot V; de Jong BA; Klein M; Ruitenberg MFL; Schaafsma FG; Schippers ECF; Schoonheim MM; Uitdehaag BMJ; van der Veen S; Waskowiak PT; Widdershoven GAM; van der Hiele K; Hulst HE;
    BMC Neurol; 2024 Jan; 24(1):28. PubMed ID: 38225561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation: a randomized controlled pilot and feasibility study [ReFEx].
    Wolf F; Nielsen J; Saliger J; Hennecken E; Kröber P; Eschweiler M; Folkerts AK; Karbe H; Zimmer P
    BMC Neurol; 2023 Oct; 23(1):388. PubMed ID: 37898772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
    Neven A; Janssens D; Alders G; Wets G; Van Wijmeersch B; Feys P
    Disabil Rehabil; 2013 Sep; 35(20):1718-25. PubMed ID: 23343357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
    Carter A; Daley A; Humphreys L; Snowdon N; Woodroofe N; Petty J; Roalfe A; Tosh J; Sharrack B; Saxton JM
    Mult Scler; 2014 Jul; 20(8):1112-22. PubMed ID: 24421303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pragmatic exercise intervention for people with multiple sclerosis (ExIMS trial): study protocol for a randomised controlled trial.
    Saxton JM; Carter A; Daley AJ; Snowdon N; Woodroofe MN; Petty J; Roalfe A; Tosh J; Sharrack B
    Contemp Clin Trials; 2013 Mar; 34(2):205-11. PubMed ID: 23123791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study.
    D'hooghe M; Van Gassen G; Kos D; Bouquiaux O; Cambron M; Decoo D; Lysandropoulos A; Van Wijmeersch B; Willekens B; Penner IK; Nagels G
    Mult Scler Relat Disord; 2018 May; 22():90-96. PubMed ID: 29649789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity interval training and energy management education, compared with moderate continuous training and progressive muscle relaxation, for improving health-related quality of life in persons with multiple sclerosis: study protocol of a randomized controlled superiority trial with six months' follow-up.
    Patt N; Kool J; Hersche R; Oberste M; Walzik D; Joisten N; Caminada D; Ferrara F; Gonzenbach R; Nigg CR; Kamm CP; Zimmer P; Bansi J
    BMC Neurol; 2021 Feb; 21(1):65. PubMed ID: 33573608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised controlled pilot and feasibility study of multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation (ReFEx): study protocol.
    Wolf F; Nielsen J; Saliger J; Hennecken E; Eschweiler M; Folkerts AK; Karbe H; Zimmer P
    BMJ Open; 2022 Sep; 12(9):e062160. PubMed ID: 36357342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups.
    El-Wahsh S; Balandin S; Bogaardt H; Kumfor F; Ballard KJ
    Int J Lang Commun Disord; 2022 May; 57(3):680-694. PubMed ID: 35338749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.
    Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Birchwood M; Briggs A; Bucci S; Cotton S; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung A; Aucott L; Farhall J; Gleeson J
    Health Technol Assess; 2022 May; 26(27):1-174. PubMed ID: 35639493
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.